Abstract
Regenerating gene protein (REG) 3A is a 19 kD secretory pancreas protein with pro-growth function. Previously we demonstrated that overexpression of REG3A, acting as a key molecule for up-regulation of the JAK2/STAT3 pathway, contributed to inflammation-related pancreatic cancer (PaC) development. However the exact network associated with REG3A signaling still remains unclear. Here we determined that exposure of human PaC cells to cytokine IL-6 activated the oncogenic JAK2/STAT3 pathway, which directly upregulated REG3A expression, accelerated cell cycle progression by promoting CyclinD1 expression, and enhancing the expression of the anti-apoptosis Bcl family. Importantly, the activation of REG3A would instead enhance the JAK2/STAT3 pathway to constitute a REG3A-JAK2/STAT3 positive feedback loop, which leads to the amplification of the oncogenic effects of IL-6/JAK2/STAT3, a classic pathway linking to inflammation-related tumorigenesis, ultimately resulting in PaC cell over-proliferation and tumor formation both in vitro and in vivo. Moreover, EGFR was found to mediate the REG3A signal for PaC cell growth and JAK2/STAT3 activation, thus functioning as a REG3A receptor. Collectively, our results provide the first evidence for the presence of the synergistic effect of REG3A and IL-6 on PaC development via a REG3A-JAK2/STAT3 positive feedback loop.
Keywords:
Cell growth; Feedback loop; IL-6; Pancreatic cancer; REG3A.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Antigens, Neoplasm / biosynthesis
-
Antigens, Neoplasm / genetics
-
Antigens, Neoplasm / metabolism*
-
Antigens, Neoplasm / pharmacology
-
Biomarkers, Tumor / biosynthesis
-
Biomarkers, Tumor / genetics
-
Biomarkers, Tumor / metabolism*
-
Biomarkers, Tumor / pharmacology
-
Cell Growth Processes / drug effects
-
Cell Line, Tumor
-
Cell Movement / drug effects
-
Drug Synergism
-
ErbB Receptors / metabolism
-
Feedback, Physiological / drug effects
-
Female
-
Heterografts
-
Humans
-
Inflammation / chemically induced
-
Inflammation / metabolism
-
Inflammation / pathology
-
Interleukin-6 / genetics
-
Interleukin-6 / metabolism
-
Interleukin-6 / pharmacology*
-
Janus Kinase 2 / metabolism*
-
Lectins, C-Type / biosynthesis
-
Lectins, C-Type / genetics
-
Lectins, C-Type / metabolism*
-
Mice
-
Mice, Inbred BALB C
-
Mice, Nude
-
Pancreatic Neoplasms / genetics
-
Pancreatic Neoplasms / metabolism*
-
Pancreatic Neoplasms / pathology*
-
Pancreatitis-Associated Proteins
-
RNA, Small Interfering / administration & dosage
-
RNA, Small Interfering / genetics
-
Random Allocation
-
Recombinant Proteins / pharmacology
-
STAT3 Transcription Factor / metabolism*
-
Signal Transduction / drug effects
-
Transfection
Substances
-
Antigens, Neoplasm
-
Biomarkers, Tumor
-
Interleukin-6
-
Lectins, C-Type
-
Pancreatitis-Associated Proteins
-
REG3A protein, human
-
RNA, Small Interfering
-
Recombinant Proteins
-
Reg3a protein, mouse
-
STAT3 Transcription Factor
-
STAT3 protein, human
-
EGFR protein, human
-
ErbB Receptors
-
JAK2 protein, human
-
Janus Kinase 2